
STERIS plc
STERIS plc (STE) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
STE · free cash flow · updated Jun 8, 2026
Core FCF metrics
STE · FCF · TTM · margin & CAGRFree cash flow was $972.4M for FY2026 (fiscal year ending 2026-03-31), up 25.0% year-over-year The FCF margin was 16.4%. Five-year CAGR stands at +16.6%.
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
STE · P/FCF · FCF yield · FCF per shareSTERIS plc (STE) trades at a FCF yield of 4.72% and a price-to-free-cash-flow ratio of 21.3x. FCF per share stands at $9.90, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.
Cash flow statement summary
STE · cash flow statement · operating / investing / financingFor FY2026, STERIS plc generated $1.34B in operating cash flow and spent 369M in capital expenditures, yielding $972.4M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Healthcare)
About Free Cash Flow & Methodology
STERIS plc (STE) reported free cash flow of $972.4M for FY2026 (fiscal year ending 2026-03-31), up 25.0% year-over-year. The FCF margin was 16.4%.
Based on available data, STERIS plc has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $972.4M in FY2026. The 5-year CAGR stands at +16.6%.
STERIS plc's FCF yield is 4.72% and price-to-FCF ratio is 21.3x for FY2026, based on the latest available data.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
STE free cash flow · 8 questionsSTERIS plc free cash flow was $972.4M for FY2026, up 25.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $972.4M.
▸ Source: FMP /cash-flow-statement · US GAAP · STERIS plc · STERIS plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026